Key references: Assessing suitability of depot medroxyprogesterone contraception
Chotnopparatpattara P, Taneepanichskul S. Use of depot medroxyprogesterone acetate in Thai adolescents. Contraception 2000;62(3):137–40. https://www.ncbi.nlm.nih.gov/pubmed/11124361
Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR, Jr. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception 2004;70(1):11–8. https://www.ncbi.nlm.nih.gov/pubmed/15208047
Nelson AL, Katz T. Initiation and continuation rates seen in 2-year experience with same day injections of DMPA. Contraception 2007;75(2):84–7. https://www.ncbi.nlm.nih.gov/pubmed/17241834
Pardthaisong T. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis. J Biosoc Sci 1984;16(1):23–34. https://www.ncbi.nlm.nih.gov/pubmed/6230362
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117(5):1105–13. https://www.ncbi.nlm.nih.gov/pubmed/21508749
Sangi-Haghpeykar H, Poindexter AN, Bateman L, Ditmore JR. Experiences of injectable contraceptive users in an urban setting. Obstet Gynecol 1996;88(2):227–33. https://www.ncbi.nlm.nih.gov/pubmed/8692507
Schaffir J, Worly BL, Gur TL. Combined hormonal contraception and its effects on mood: a critical review. Eur J Contracept Reprod Health Care 2016;21(5):347–55. https://www.ncbi.nlm.nih.gov/pubmed/27636867
Schwallie PC, Assenzo JR. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception 1974;10(2):181–202. https://www.ncbi.nlm.nih.gov/pubmed/4419530
Skovlund CW, Morch LS, Kessing LV, Lidegaard O. Association of hormonal contraception with depression. JAMA Psychiatry 2016;73(11):1154–62. https://www.ncbi.nlm.nih.gov/pubmed/27680324
